Compound ID | 2703
Class: Antimicrobial peptide
| Agent Type: | Natural product; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Streptococcus pyogenes including Streptococcus pneumoniae, Streptococcus mutans, and Staphylococcus aureus |
| Description: | Engineered natural product from the oral probiotic Streptococcus salivarius K12; in vivo potency comparable to penicillin G in mice Group A streptococci infection; lantibiotic-type |
| Institute where first reported: | Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, TX, USA |
| Year first mentioned: | 2024 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||||
|
|
||||||||||||
|
|
||||||||||||
| External links: | |
| Citation: | https://www.nature.com/articles/s41564-023-01583-9 |